As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of a recent study titled: Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom.
Independent expert commentary is provided by Dr Anthony Dortimer, an Interventional Cardiologist working at the Austin Hospital and Warringal Hospital in Melbourne, and the Royal Flying Doctor Service’s Cardiologist in Victoria.
Please login below to download this issue (PDF)